Literature DB >> 27546893

The relationship between serum paraoxonase levels and carotid atherosclerotic plaque formation in Alzheimer's patients.

Ayşe Arslan1, Fatma Aykan Tüzün2, Harun Arslan3, Halit Demir4, Sibel Tamer5, Canan Demir6, Muhterem Tasin7.   

Abstract

Low paraoxonase 1 (PON1) activity and carotid atherosclerosis have been suggested to be important risk factors for dementia. However, the studies to date could not fully clarify the relationship between PON1, carotid atherosclerosis and dementia. The present study aimed to measure carotid atherosclerosis and PON1 activity in Alzheimer's Disease and to evaluate the relationship between them. The study included 25 Alzheimer's patients and 25 control subjects, for a total of 50 individuals. The study measured the serum PON1 activity and other biochemical parameters and carotid atherosclerotic plaque values of the participants. The mean paraoxonase activity (31.06±2.31U/L) was significantly lower in the Alzheimer's group compared to the control group (59.05±7.05U/L) (P<0.001). Nonetheless, the carotid plaque values were significantly higher in the patient group (3.02±0.52mm) compared to the control group (1.84±0.45mm) (P<0.001). Furthermore, there was a negative correlation (81.0%) between PON1 activity and carotid plaque in the overall study group (P<0.05). Also serum homocystein level was higher in the patient group (22.15±7.05) compared to the control group (13.30±3.32). In conclusion, our findings show inverse association between PON1 activity and carotid atherosclerosis in Alzheimer patients: the lower the PON1 activity the more progressed the atherosclerotic process in AD.
Copyright © 2016 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Carotid atherosclerosis; Homocystein; PON1

Mesh:

Substances:

Year:  2016        PMID: 27546893     DOI: 10.1016/j.pjnns.2016.07.002

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  4 in total

Review 1.  Paraoxonase and arylesterase activity of serum PON-1 enzyme in psoriatic patients: a systematic review and meta-analysis.

Authors:  Stefania Bassu; Arduino A Mangoni; Rosanna Satta; Dario Argiolas; Ciriaco Carru; Angelo Zinellu
Journal:  Clin Exp Med       Date:  2022-03-21       Impact factor: 5.057

Review 2.  Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development.

Authors:  Carlo Cervellati; Giuseppe Valacchi; Veronica Tisato; Giovanni Zuliani; Judit Marsillach
Journal:  Minerva Med       Date:  2018-10-11       Impact factor: 4.806

3.  Expression levels of atherosclerosis-associated miR-143 and miR-145 in the plasma of patients with hyperhomocysteinaemia.

Authors:  Kejian Liu; Saiyare Xuekelati; Yue Zhang; Yin Yin; Yue Li; Rui Chai; Xinwei Li; Yi Peng; Jiangdong Wu; Xiaomei Guo
Journal:  BMC Cardiovasc Disord       Date:  2017-06-20       Impact factor: 2.298

Review 4.  A review of the mechanisms underlying selected comorbidities in Alzheimer's disease.

Authors:  Karolina Maciejewska; Kamila Czarnecka; Paweł Szymański
Journal:  Pharmacol Rep       Date:  2021-06-13       Impact factor: 3.024

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.